SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : APPI - Advanced Plant Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: SCOOBEY-DO who wrote (1241)6/18/2002 7:14:59 PM
From: SCOOBEY-DO  Respond to of 1263
 
APPI filed their March 31, 2002 10-Q today, little over a
month late. Their cash flow looks interesting in that $260M
was Amortization Exp. and $370M was for services paid with stock.
It looks like they paid off $212M in debt without generating more debt.

The following is their cash flow for the quarter:

ADVANCED PLANT PHARMACEUTICALS, INC.
------------------------------------
STATEMENTS OF CASH FLOWS
------------------------
FOR THE THREE MONTHS ENDED MARCH 31, 2002 AND 2001
--------------------------------------------------
(UNAUDITED)
-----------

2001 2001
--------------- -------------
Cash Flows from Operating Activities:

Net Loss from operations $ (436,818) $ (173,787)

Adjustments to reconcile net loss from
operations to net cash used by operating
activities:

Depreciation and amortization expense 259,799 242
Inventory Adjustment 891
Services paid with common stock 370,200 -
Decrease in Accounts Receivable 1,454 -
(Decrease) Increase in accounts payable 4,460 11,769
Increase in accrued expenses 4,885 119,876

Net cash used by operations 204,871 (41,900)
--------------- -------------

Cash Flows from Investing Activities:

Purchase of computer equipment - -

Net cash used by investing activities - -
--------------- -------------

Cash Flows from Financing Activities:

Proceeds from short-term loans payable 0 41,900
Repayments on short-term loans payable (212,000) -

Net cash provided by financing activities (212,000) 41,900
--------------- -------------

Net increase in Cash and cash equivalents (7,129) -

Cash and cash equivalents at beginning of period 7,316 -

Cash and cash equivalents at end of period $ 187 $ -
=============== =============